← Back to Search

Retinoid

Altreno for Acne

Phase 4

Waitlist Available

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

A confirmed diagnosis of acne that warrants initiating topical medications.

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 90 days after treatment, and followed by 30 days of no treatment

Awards & highlights

Study Summary

This trial is studying how well two acne treatments work compared to each other.

Eligible Conditions

Acne
Healthy Subjects

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You have acne that needs to be treated with topical medications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 90 days after treatment, and followed by 30 days of no treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 90 days after treatment, and followed by 30 days of no treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 90 days after treatment, and followed by 30 days of no treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CLR-transformed Abundance of Any Significant Taxa

Secondary outcome measures

Change in Leeds score

Change in the lesion count of inflammatory and non-inflammatory

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: BPO GroupExperimental Treatment1 Intervention

Group II: Altreno GroupExperimental Treatment1 Intervention

Group III: Control GroupActive Control1 Intervention

During the entire study period, the subjects in the control group will not be allowed to use any antibacterial wash, other than approved OTC cleansers.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Tretinoin

FDA approved

Benzoyl peroxide

FDA approved

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ortho DermatologicsIndustry Sponsor

4 Previous Clinical Trials

1,196 Total Patients Enrolled

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,311 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you detail the other experiments that have been conducted using Altreno?

"As of today, Altreno is the subject of 23 separate trials with 5 at Phase 3. These studies are distributed across 264 different sites in and around New york City."

Answered by AI

Do I meet the criteria to join this clinical investigation?

"This medical trial requires participants to be between 18 and 40 years old, as well as suffering from acne. 60 individuals are needed in total."

Answered by AI

Are there any potential risks associated with Altreno treatment?

"As this is a Phase 4 trial, which signifies that Altreno has been approved by the relevant authorities, we rate its safety as 3 on our scale of 1 to 3."

Answered by AI

What medical conditions is Altreno generally prescribed to address?

"Altreno is commonly prescribed to treat severe, persistent cystic acne and other conditions like dermatologic disorders, inflammatory acne vulgaris, and facial skin coarseness."

Answered by AI

Is the age limit for participants of this trial restricted to over 70 or is it lower?

"The enrolling patient population for this trial must be between 18 to 40 years old. There are 72 trials specifically targeting those under the age of consent and 410 clinical studies seeking elderly participants over 65."

Answered by AI

How many subjects have been enrolled in this experiment thus far?

"Affirmative. Clinicaltrials.gov provides evidence that this medical research is actively attempting to enlist participants, beginning on April 23rd 2021 and last updated August 9th 2022. The trial requires 60 patients from a single site for its completion."

Answered by AI

Are investigators still enrolling participants for this trial?

"Per the details on clinicaltrials.gov, this trial is still in search of participants. This study was initially published on April 23rd 2021 and later modified on August 9th 2022."

Answered by AI